Question 1

Does Barclays own SMMT stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Barclays holds 210,207 shares of SMMT (Summit Therapeutics), worth $3.1M.

Question 2

How many shares of SMMT does Barclays own?

Accepted Answer

As of its Q2 2026 13F, Barclays holds 210,207 shares of SMMT (Summit Therapeutics).

Question 3

What is Barclays' SMMT position worth?

Accepted Answer

As of its Q2 2026 13F, Barclays' SMMT position is worth $3.1M.

Question 4

Is Barclays buying or selling SMMT?

Accepted Answer

In Q2 2026, Barclays increased its SMMT position from 49,103 to 210,207 shares.

Question 5

When did Barclays first buy SMMT?

Accepted Answer

Barclays first reported SMMT in its Q1 2022 13F and has listed it in 18 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	210,207	+328.1%	$3.1M	0.0%	$14.57	43
2026-Q1	Decreased	49,103	-85.5%	$930,993	0.0%	$18.96	0
2025-Q4	Decreased	338,390	-28.9%	$5.9M	0.0%	$17.49	0
2025-Q3	Increased	475,777	+51.6%	$9.8M	0.0%	$20.66	39
2025-Q2	Increased	313,824	+22.8%	$6.7M	0.0%	$21.28	33
2025-Q1	Decreased	255,612	-22.6%	$4.9M	0.0%	$19.29	0
2024-Q4	Increased	330,146	+32.0%	$5.9M	0.0%	$17.85	35
2024-Q3	Decreased	250,118	-35.4%	$5.5M	0.0%	$20.89	0